Skip to main content

Cipla 446 Pill - red blue capsule/oblong, 23mm

Pill with imprint Cipla 446 is Red / Blue, Capsule/Oblong and has been identified as Atazanavir Sulfate 300 mg. It is supplied by Cipla USA Inc.

Atazanavir is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 446

Atazanavir sulfate 300 mg Cipla 446
Atazanavir sulfate 300 mg Cipla 446

Atazanavir Sulfate

Cipla 446
300 mg
Red / Blue
23.00 mm
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose monohydrate, crospovidone, magnesium stearate, gelatin, sodium lauryl sulfate, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40, D&C Yellow No. 10, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.